- Trials with a EudraCT protocol (29)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
29 result(s) found for: Amygdala.
Displaying page 1 of 2.
EudraCT Number: 2008-003123-24 | Sponsor Protocol Number: ppiller1 | Start Date*: 2009-01-21 | |||||||||||
Sponsor Name:Uppsala University | |||||||||||||
Full Title: Neuroanatomical and functional abnormalities in patients with aversive effects from oral contraceptives. | |||||||||||||
Medical condition: Healthy women with previous adverse reaction to oral contraceptives | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001802-32 | Sponsor Protocol Number: C1501 | Start Date*: 2015-08-14 | |||||||||||
Sponsor Name:Biologische Heilmittel Heel GmbH | |||||||||||||
Full Title: Neuronal correlates of Neurexan® action in mildly to moderately stressed probands - a randomized, placebo-controlled, double-blind, cross-over trial of mode of action and response prediction by fun... | |||||||||||||
Medical condition: mildly to moderately stressed probands | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001371-30 | Sponsor Protocol Number: D1443L00051 | Start Date*: 2009-02-16 |
Sponsor Name:Universitätsklinikum Münster | ||
Full Title: Anxiolytic effects of single-dose quetiapine XR administration on clinical symptoms and amygdala activation during exposure in patients with simple phobia | ||
Medical condition: simple phobia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001212-30 | Sponsor Protocol Number: ECEP-BPD | Start Date*: 2018-09-18 | |||||||||||
Sponsor Name:Central Institute of Mental Health, represented by commercial and administrative Director | |||||||||||||
Full Title: A trial to study effects of a single dose Citalopram on emotion processing in female patients with Borderline Personality Disorder and the associated modulation of fMRI BOLD signals | |||||||||||||
Medical condition: Borderline Personality Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023044-32 | Sponsor Protocol Number: DCS-fMRIPanik | Start Date*: 2011-08-10 |
Sponsor Name:Charité Universitaetsmedizin Berlin | ||
Full Title: Mechanisms of action in exposure therapy: Decoding the neural basis of fear extinction and its pharmacological modulation in patients with panic disorder | ||
Medical condition: panic disorder and agoraphobia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004074-24 | Sponsor Protocol Number: PGB04/2005 | Start Date*: 2006-02-03 |
Sponsor Name:Gesellschaft für Epilepsieforschung e.V. | ||
Full Title: Effectiveness and safety of pregabalin in patients with epilepsy and anxiety disorder. | ||
Medical condition: Focal epilepsy, anxiety disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023446-70 | Sponsor Protocol Number: | Start Date*: 2011-07-22 |
Sponsor Name:Med. Univ. Wien, Univ. Klinik für Psychiatrie und Psychotherapie | ||
Full Title: Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response | ||
Medical condition: Major Depressive Disorder (MDD) remains to be under-recognized and under-treated, though it is amongst the leading causes of disease burden worldwide. Despite the proven efficacy of modern antidepr... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003750-89 | Sponsor Protocol Number: KKS-186 | Start Date*: 2013-02-14 | |||||||||||
Sponsor Name:Philipps-University Marburg | |||||||||||||
Full Title: A placebo-controlled, double blind, randomised trial with crossover-design investigating the effect of oxytocin nasal spray on neuronal processes of empathy | |||||||||||||
Medical condition: high-functioning autism spectrum disorders: autistic disorder (F84.0), Asperger syndrome (F84.5), atypical autism (F 84.1) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003336-12 | Sponsor Protocol Number: FatherTrials2015 | Start Date*: 2016-03-23 | ||||||||||||||||
Sponsor Name:Universiteit Leiden | ||||||||||||||||||
Full Title: Father Trials: Hormonal Experiments on Prenatal and Postnatal Parenting | ||||||||||||||||||
Medical condition: There are no medical conditions or diseases under investigation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003409-25 | Sponsor Protocol Number: S61887 | Start Date*: 2018-11-08 |
Sponsor Name:KU Leuven | ||
Full Title: Dose-dependent effects of propranolol on extinction learning and return of fear | ||
Medical condition: Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test whether propranolol admin... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000712-30 | Sponsor Protocol Number: ABR-71432 | Start Date*: 2021-06-07 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Targeted glucocorticoid administration to improve safety learning in PTSD patients with HPA axis dysregulation | |||||||||||||
Medical condition: Posttraumatic Stress Disorder (PTSD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000454-22 | Sponsor Protocol Number: NL43068.058.13 | Start Date*: 2013-08-21 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: (Grand)parenting, oxytocin, and the oxytocin receptor gene: an fMRI and observational study | |||||||||||||
Medical condition: There are no medical conditions or diseases under investigation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004937-15 | Sponsor Protocol Number: BNC210.006 | Start Date*: 2015-04-16 | |||||||||||
Sponsor Name:BIONOMICS LIMITED | |||||||||||||
Full Title: A randomized, double-blinded, placebo and lorazepam-controlled, four-way crossover, Phase II study to evaluate the effects of single oral administration of BNC210 on brain activity changes captured... | |||||||||||||
Medical condition: Generalized Anxiety Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004823-66 | Sponsor Protocol Number: ELTCAN1 | Start Date*: 2019-04-17 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Early-life stress, the endocannabinoid system, and fear memory extinction | |||||||||||||
Medical condition: healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001965-36 | Sponsor Protocol Number: FAAHIPTSD | Start Date*: 2020-08-26 |
Sponsor Name:Linkoping University | ||
Full Title: Effects of the FAAH inhibitor JNJ-42165279 in combination with internet-based cognitive behavioral therapy in PTSD | ||
Medical condition: post traumatic stress disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005534-36 | Sponsor Protocol Number: Scope | Start Date*: 2008-02-04 |
Sponsor Name:King's College Hospital [...] | ||
Full Title: The effect of Exenatide on satiety, metabolic parameters and regional brain activation in response to nutrient ingestion in Type 2 diabetes. | ||
Medical condition: The brainメs response to food ingestion can be imaged and preliminary data suggest that these responses are different in the obese and insulin resistant. We will investigate the hypothesis that Exen... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001779-35 | Sponsor Protocol Number: 4 | Start Date*: 2013-02-15 | |||||||||||
Sponsor Name:University of Southampton | |||||||||||||
Full Title: The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder | |||||||||||||
Medical condition: Generalised anxiety disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000473-83 | Sponsor Protocol Number: PET-tau-FACEHBI | Start Date*: 2021-12-15 |
Sponsor Name:Fundació ACE-Institut Català de Neurociències Aplicades | ||
Full Title: PET imaging study of the brain tau deposit in individuals with subjective cognitive decline and mild cognitive impairment: FACEHBI cohort. | ||
Medical condition: Subjective cognitive impairment and mild cognitive decline in evaluation for diagnosis of Alzheimer's Disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002161-56 | Sponsor Protocol Number: NeM-CSM-FT-01 | Start Date*: 2017-04-13 |
Sponsor Name:Mateusz Gola | ||
Full Title: Towards the understanding of neuronal mechanisms of compulsive sexual behaviors - pharmacotherapy | ||
Medical condition: compulsive sexual behavior (hypersexual disorder) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: PL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001818-14 | Sponsor Protocol Number: RELATE-TRD | Start Date*: 2013-12-20 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: RELATE and PREDICT TRD A pharmacological and neuroimaging study investigating neurobiological effects of Selective Serotonin Reuptake Inhibitors and Norepinephrine Reuptake inhibitors on dopaminer... | |||||||||||||
Medical condition: Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
